Acute Kidney Injury Associated with Novel Anticancer Therapies
Kidney360 · 2025
DOI: 10.34067/kid.0000000749 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Kidney360, 2025. Verfasst von Sabine Karam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Medicine, University of Minnesota, Minneapolis, Minneapolis. Hauptthemen laut MEDLINE: Acute Kidney Injury, Immune Checkpoint Inhibitors, Neoplasms, Immunotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The landscape of cancer survival has been positively affected by the introduction and dissemination of immunotherapy with the wide usage of immune checkpoint inhibitors and chimeric antigen receptors cell therapies. The success of these novel therapies can, however, be limited to a certain extent by systemic inflammatory toxicities affecting, directly or indirectly, the kidney. In the case of immune checkpoint inhibitors, severe acute interstitial nephritis is the main adverse event and can lead to permanent discontinuation of the therapy. In turn, chimeric antigen receptor cell therapy can cause cytokine release syndrome and immune effector cell-associated hemophagocytic lympho-histiocytosis, with kidney damage through various mechanisms, and be life threatening. Prompt diagnosis and management of these entities is essential to preserve kidney function and ensure the best possible kidney and overall outcomes to patients with cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, Department of Medicine, University of Minnesota, Minneapolis, Minneapolis.
- Division of Nephrology and Hypertension, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
- Nephrology and Renal Transplantation Center, The Medical City, Baghdad, Iraq.
- Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
- Department of Hematology, Medical Oncology and Bone Marrow Transplantation, Amrita Institute of Medical Sciences and Research Centre, Faridabad, India.
- Department of Nephrology, Madras Medical Mission, Chennai, India.
ORCID-Profile: Sabine Karam, Ala Ali, Winston Fung, Prashant Mehta, Sanjeev Nair, Urmila Anandh
Zitieren
APA
Karam, S., Ali, A., Fung, W., Mehta, P., Nair, S., & Anandh, U. (2025). Acute Kidney Injury Associated with Novel Anticancer Therapies. Kidney360. https://doi.org/10.34067/kid.0000000749
Vancouver
Karam S, Ali A, Fung W, Mehta P, Nair S, Anandh U. Acute Kidney Injury Associated with Novel Anticancer Therapies. Kidney360. 2025. doi:10.34067/kid.0000000749
BibTeX
@article{Karam2025,
author = {Karam, Sabine and Ali, Ala and Fung, Winston and Mehta, Prashant and Nair, Sanjeev and Anandh, Urmila},
title = {Acute Kidney Injury Associated with Novel Anticancer Therapies},
journal = {Kidney360},
year = {2025},
doi = {10.34067/kid.0000000749}
}
EUVIMED